MRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits

Project Details

Short titleMRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits
StatusFinished
Effective start/end date1/03/2030/09/21